GAST and pancreatic neoplasm: We previously showed that CCK-BR targeted NPs delivering a gastrin (GAST) siRNA payload could prevent pancreatic cancer metastases in mice bearing PANC-1 and BxPC-3 tumors when treatment with nanoparticles was initiated one week after tumor cell inoculation.